Unveiling the Future of Immunotherapy: What Evaxion Biotech’s Bold Moves Mean for the Market
Evaxion Biotech A/S is preparing transformative proposals for its Annual General Meeting on April 30, 2025, focusing on reshaping its identity and financial strength. The company specializes in AI-driven therapies…